Risk stratification after recurrence of human papillomavirus ( HPV) ‐related and non‐HPV ‐related oropharyngeal cancer: Secondary analysis of NRG Oncology RTOG 0129 and 0522-Reference-Cited by-同舟云学术

Risk stratification after recurrence of human papillomavirus ( HPV) ‐related and non‐HPV ‐related oropharyngeal cancer: Secondary analysis of NRG Oncology RTOG 0129 and 0522

Published:2021-11-03 Issue:1 Volume:44 Page:158-167
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head & Neck

Author:

Bigelow Elaine O.¹^ORCID,Harris Jonathan²,Fakhry Carole¹,Gillison Maura L.³,Nguyen‐Tân Phuc Felix⁴,Rosenthal David I.³,Frank Steven J.³^ORCID,Nair Suresh G.⁵,Bahig Houda⁴^ORCID,Ridge John A.⁶,Caudell Jimmy⁷,Donaldson Craig⁸,Clifford Bradley T.⁹,Shenouda George¹⁰,Birrer Michael J.¹¹,Chen Yuhchyau¹²,Le Quynh‐Thu¹³

Affiliation:

1. Department of Otolaryngology – Head & Neck Surgery Johns Hopkins University Baltimore Maryland USA

2. NRG Oncology Statistics and Data Management Center American College of Radiology Philadelphia Pennsylvania USA

3. The University of Texas M. D. Anderson Cancer Center Houston Texas USA

4. Department of Radiation Oncology Centre Hospitalier de l'Universite de Montreal Montreal Quebec Canada

5. Department of Hematology and Oncology Lehigh Valley Hospital Allentown Pennsylvania USA

6. Department of Surgical Oncology Fox Chase Cancer Center Philadelphia Pennsylvania USA

7. H. Lee Moffitt Cancer Center and Research Institute Tampa Florida USA

8. Intermountain Medical Center St. George Utah USA

9. Department of Oncology Summa Health System – Akron Campus Akron Ohio USA

10. Department of Radiation Oncology The Research Institute of the McGill University Health Centre (MUHC) Montreal Quebec Canada

11. Department of Medical Oncology University of Alabama at Birmingham Cancer Center Birmingham Alabama USA

12. Department of Radiation Oncology University of Rochester Rochester New York USA

13. Department of Radiation Oncology Stanford University Stanford California USA

Funder

National Cancer Institute

Publisher

Wiley

Subject

Otorhinolaryngology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hed.26915

Reference25 articles.

1. Epidemiology of Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma

2. Worldwide Trends in Incidence Rates for Oral Cavity and Oropharyngeal Cancers

3. Increasing prevalence of human papillomavirus-positive oropharyngeal cancers among older adults

4. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region

5. Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lead Time to Recurrence After Posttreatment Plasma and Saliva HPV DNA Testing in Patients With Low-Risk HPV Oropharynx Cancer;JAMA Otolaryngology–Head & Neck Surgery;2023-09-01

2. The Lack of Standardized Outcomes for Surgical Salvage of HPV-Positive Recurrent Oropharyngeal Squamous Cell Carcinoma: A Systematic Scoping Review;Cancers;2023-05-19

3. Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504;International Journal of Radiation Oncology*Biology*Physics;2023-03

4. HPV Prevalence and Predictive Biomarkers for Oropharyngeal Squamous Cell Carcinoma in Mexican Patients;Pathogens;2022-12-13